---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-24-000043"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2024-01-10T23:59:59+00:00"
generated_at: "2026-06-07T01:00:26.185233+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Clover Health targets Adjusted EBITDA profitability for full-year 2024

## Summary
- Targets Adjusted EBITDA profitability for full-year 2024.
- CEO Andrew Toy cites strong 2023 Insurance performance and Clover Assistant technology.
- Plans to focus on member retention rather than expansion in core markets.
- Will issue full-year 2024 guidance at a later date.
- Presentation at 42nd Annual J.P. Morgan Healthcare Conference on Jan 11, 2024.

## SEC filing metadata
- accession: 0001801170-24-000043
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2024-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000043/0001801170-24-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117024000043/clov-20240110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-24-000043
- JSON: https://secwatch.observer/filing/0001801170-24-000043.json
- Plain text: https://secwatch.observer/filing/0001801170-24-000043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.